Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy.

MLA

Yu-Hsuan Lin, et al. “Pretreatment Combination of Platelet Counts and Neutrophil-Lymphocyte Ratio Predicts Survival of Nasopharyngeal Cancer Patients Receiving Intensity-Modulated Radiotherapy.” OncoTargets & Therapy, vol. 10, May 2017, pp. 2751–60. EBSCOhost, https://doi.org/10.2147/OTT.S137000.

APA

Yu-Hsuan Lin, Kuo-Ping Chang, Yaoh-Shiang Lin, & Ting-Shou Chang. (2017). Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy. OncoTargets & Therapy, 10, 2751–2760. https://doi.org/10.2147/OTT.S137000

Chicago

Yu-Hsuan Lin, Kuo-Ping Chang, Yaoh-Shiang Lin, and Ting-Shou Chang. 2017. “Pretreatment Combination of Platelet Counts and Neutrophil-Lymphocyte Ratio Predicts Survival of Nasopharyngeal Cancer Patients Receiving Intensity-Modulated Radiotherapy.” OncoTargets & Therapy 10 (May): 2751–60. doi:10.2147/OTT.S137000.